Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, September 7, 2023
[ Thu, Sep 07th 2023
] - WOPRAI
[ Thu, Sep 07th 2023
] - WOPRAI
[ Thu, Sep 07th 2023
] - WOPRAI
[ Thu, Sep 07th 2023
] - WOPRAI
[ Thu, Sep 07th 2023
] - WOPRAI
[ Thu, Sep 07th 2023
] - WOPRAI
[ Thu, Sep 07th 2023
] - WOPRAI
[ Thu, Sep 07th 2023
] - WOPRAI
[ Thu, Sep 07th 2023
] - WOPRAI
[ Thu, Sep 07th 2023
] - WOPRAI
[ Thu, Sep 07th 2023
] - WOPRAI
[ Thu, Sep 07th 2023
] - WOPRAI
[ Thu, Sep 07th 2023
] - WOPRAI
[ Thu, Sep 07th 2023
] - WOPRAI
[ Thu, Sep 07th 2023
] - WOPRAI
[ Thu, Sep 07th 2023
] - WOPRAI
[ Thu, Sep 07th 2023
] - WOPRAI
[ Thu, Sep 07th 2023
] - WOPRAI
[ Thu, Sep 07th 2023
] - WOPRAI
[ Thu, Sep 07th 2023
] - WOPRAI
[ Thu, Sep 07th 2023
] - WOPRAI
[ Thu, Sep 07th 2023
] - WOPRAI
[ Thu, Sep 07th 2023
] - WOPRAI
[ Thu, Sep 07th 2023
] - WOPRAI
[ Thu, Sep 07th 2023
] - WOPRAI
[ Thu, Sep 07th 2023
] - WOPRAI
[ Thu, Sep 07th 2023
] - WOPRAI
Wed, September 6, 2023
[ Wed, Sep 06th 2023
] - WOPRAI
Morten Herholdt Initiated (BLUE) at Strong Buy and Held Target at $4.21 on, Sep 6th, 2023
Morten Herholdt of HSBC, Initiated "bluebird bio, Inc." (BLUE) at Strong Buy and Held Target at $4.21 on, Sep 6th, 2023.
Morten has made no other calls on BLUE in the last 4 months.
There are 3 other peers that have a rating on BLUE. Out of the 3 peers that are also analyzing BLUE, 0 agree with Morten's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Morten
- Jason Gerberry of "B of A Securities" Upgraded from Hold to Strong Buy and Increased Target to $10 on, Wednesday, July 19th, 2023
- Matthew Harrison of "Morgan Stanley" Reiterated at Sell and Held Target at $3 on, Tuesday, July 11th, 2023
- Gena Wang of "Barclays" Upgraded from Hold to Buy and Increased Target to $8 on, Thursday, June 1st, 2023
